Autoantibodies sign for the early detection of ovarian cancer

摘要

P- potential methods of identifying antigen as a biomarker, as well as biomarkers and personalized medicine / therapeutic kit for use of the antigen in the evaluation for the early detection of ovarian cancer. Developed a protein microarray to present a candidate antigen of a full-length, in order to limit the specific false discovery rate in large-scale proteomic screening, was selected candidate autoantibody biomarker performs a sequential screening.